BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

Latest News

Salt AI Raises $10M for Drag-and-Drop Platform …

Salt AI Raises $10M for Drag-and-Drop Platform to Build AI Workflows in Life Sciences

Salt AI closed a $10 million round led by Morpheus Ventures, with Struck Capital, Marbruck Investments, and CoreWeave participating. The company plans to expand deployments … Read More

Trially AI Raises $4.7M Seed Round, Launches …

Trially AI Raises $4.7M Seed Round, Launches AI for Clinical Trial Enrollment

Trially AI has secured $4.7 million in seed financing led by Flyover Capital, with participation from Alpaca, Atria, Blu Ventures, Looking Glass Capital, Redbud, The … Read More

Helmholtz Munich and Parse Biosciences Partner to …

Helmholtz Munich and Parse Biosciences Partner to Build Largest Human Lung Tissue Perturbation Atlas

Helmholtz Munich and Parse Biosciences have launched a collaboration to generate an atlas of human lung tissue perturbations. The project uses Parse’s GigaLab single-cell sequencing … Read More

Immuto Raises $8M Seed for AI Structural Surfaceomics, Enters Daiichi Sankyo Oncology Collaboration

T.Rx Capital Raises $77.5M to Back Early-Stage Biotech and Digital Health

Enveda Starts Phase 1b of AI-Discovered Small-Molecule Anti-Inflammatory for Atopic Dermatitis

UK Health-AI Push: NVIDIA Partnerships Back Sovereign Models from Imaging to Drug Design

Stanford–Arc Team Reports AI-Made Viruses That Kill Bacteria

Google-Backed BenchSci Reports New System to Extract Experimental Context From Biomedical Papers Into a Traceable Evidence Graph

Read latest news ›››

Latest Insights

Novotech Report: Over 800 Global IPF Trials …

by BiopharmaTrend

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying strategic trends for drug developers … Read More

Into the Unknown — How Artificial Intelligence …

by Louise von Stechow

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

With DeepMind’s release of AlphaGenome—a deep learning model that can predict the relevance of variants in both coding and non-coding DNA—the so-called “dark genome” has … Read More

Phesi Reports GLP-1 Trials Now Span 100+ Diseases

by Anastasiia Rohozianska

Digital Twins in Rare Diseases: From Virtual Trials to Personalized Care

by Louise von Stechow

How AI Is Transforming Medicinal Chemistry Between Discovery and Manufacture

by Andrii Buvailo, PhD

"AI Scientists" - New Collaborators for Rare Disease Research?

by Louise von Stechow

What are Foundation Models in Biology and Healthcare?

by BiopharmaTrend

The Pivotal Role of AI in Clinical Trials: From Digital Twins to Synthetic Control Arms

by BiopharmaTrend

Building AI Solutions for Life Sciences and Healthcare

by BiopharmaTrend

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

by Louise von Stechow

From Our Partners

Read All ›››

Navigating the Crossroads of AI and Oncology: …

Sponsored by Lantern Pharma

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

How AI Empowers Biomarker-Driven Clinical Trials

Sponsored by Lantern Pharma

How AI Empowers Biomarker-Driven Clinical Trials

Patented AI Platform Identifies Promising Early-Stage BioPharma …

Sponsored by Intelligencia AI

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Unlocking Interoperability with AI: How This Company …

Sponsored by Trialize

Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials

Partner Events

View all events ›››

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

Interactive Response Technologies 2025

Interactive Response Technologies 2025

Event Date: Oct. 14, 2025 - Oct. 15, 2025

Location: United States of America (The Westin Copley Place, Boston, MA)

Website: Link

KOREA LIFESCIENCE WEEK

KOREA LIFESCIENCE WEEK

Event Date: Oct. 30, 2025 - Nov. 1, 2025

Location: South Korea (coex, SEOUL)

Website: Link

Drug Discovery Innovation Programme

Drug Discovery Innovation Programme

Event Date: Sept. 25, 2025 - Sept. 26, 2025

Location: Spain (InterContinental Barcelona, Spain)

Website: Link

Case Studies

Read All ›››

From Data to Discovery: How BenchSci’s ASCEND …

Sponsored by BenchSci

From Data to Discovery: How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

AI Becomes a Drop-in Replacement for Docking

Sponsored by RECEPTOR.AI

AI Becomes a Drop-in Replacement for Docking

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

ArtiDock from Receptor.AI: Next-generation AI Docking That …

Sponsored by RECEPTOR.AI

ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest

Powering Cancer Drug Discovery and Development Using …

Sponsored by Lantern Pharma

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Interviews

Read All ›››

Combining AI and Quantum Mechanics to Improve …

Combining AI and Quantum Mechanics to Improve Drug and Vaccine Discovery

Cracking the Code of Life: An Interview …

Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering

The Synergistic Potential of AI and Synthetic …

The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández

Unlocking Interoperability with AI: How This Company …

Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials

Most Read

21 Life Science Marketplaces to Try in …

Articles

21 Life Science Marketplaces to Try in 2024

19 Companies Pioneering AI Foundation Models in …

Articles

19 Companies Pioneering AI Foundation Models in Pharma and Biotech

14 Companies Using Quantum Theory To Accelerate …

Articles

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

ArtiDock from Receptor.AI: Next-generation AI Docking That …

Case Studies

ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest